MedPath

benzonatate

Benzoate Capsules

Approved
Approval ID

446d268a-fc0f-4027-b380-1083a3a252b5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 8, 2011

Manufacturers
FDA

RedPharm Drug Inc.

DUNS: 008039641

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

benzonatate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67296-0822
Application NumberANDA040749
Product Classification
M
Marketing Category
C73584
G
Generic Name
benzonatate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 8, 2011
FDA Product Classification

INGREDIENTS (8)

titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
benzonatateActive
Quantity: 200 mg in 1 1
Code: 5P4DHS6ENR
Classification: ACTIB
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
gelatinInactive
Code: 2G86QN327L
Classification: IACT
glycerinInactive
Code: PDC6A3C0OX
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
methylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
propylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

benzonatate - FDA Drug Approval Details